APPROVAL HAS
BEEN GRANTED UNTIL JANUARY 1984 TO PERMIT THE NEW DRUG APPLICATION
[NDA] REGULATIONS TO BE PUBLISHED IN FINAL FORM. ANY FUTUR RENEWAL
REQUEST MUST JUSTIFY THE NECESSITY FOR A SEPERATE ANTIBIOTIC
APPLICATION AND MUST REFLECT THE NDA REVISIONS.
Inventory as of this Action
Requested
Previously Approved
01/31/1984
01/31/1984
05/31/1982
80
0
80
6,400
0
6,400
0
0
0
USED BY ANTIBIOTIC DRUG MANUFACTURERS
TO GAIN APPROVAL TO MARKET ANTIBIOTIC PRODUCTS IN THE U.S.A.
INFORMATION REQUESTED BY AGENCY IS NEEDED TO EVALUATE WHETHER
PRODUCTS ARE SAFE AND EFFECTIVE FOR THEIR INTENDED USE.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.